Teladoc Health, Inc.(TDOC US)
$6.34+0.020.32%Ext:$6.27-0.071.16%(Market Closed · 00:00:02 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,602.4 | 2,569.6 | 2,530.0 | 2,514.5 | ||||||||||||
| -Cost of Revenue | 760.0 | 751.3 | 771.6 | 864.6 | ||||||||||||
| Gross Profit | 1,842.4 | 1,818.3 | 1,758.4 | 1,649.9 | ||||||||||||
| -Operating Expenses | 2,090.9 | 2,839.2 | 2,021.3 | 1,840.9 | ||||||||||||
| +Selling, General & Admin | 1,367.3 | 1,346.3 | 1,085.3 | 1,060.5 | ||||||||||||
| +General And Administrative Expenses | 464.7 | 435.5 | 431.9 | 421.2 | ||||||||||||
| +Selling And Marketing Expenses | 902.6 | 910.8 | 653.4 | 639.3 | ||||||||||||
| +Research and Development | 348.5 | 307.3 | 277.9 | 320.1 | ||||||||||||
| +Other Operating Expenses | 375.1 | 1,185.6 | 658.2 | 460.3 | ||||||||||||
| Operating Income | -248.6 | -1,020.9 | -263.0 | -191.1 | ||||||||||||
| +Non Operating Income | 53.4 | 60.5 | 44.5 | 94.3 | ||||||||||||
| +Interest Income, Net | 24.5 | 33.3 | 17.1 | 88.3 | ||||||||||||
| +Interest Income | 46.8 | 57.1 | 36.8 | 107.6 | ||||||||||||
| -Interest Expense | 22.3 | 23.8 | 19.7 | 19.3 | ||||||||||||
| +Other Non-Op Income | 28.9 | 27.2 | 27.4 | 6.0 | ||||||||||||
| Pretax Income | -219.6 | -993.7 | -235.5 | -185.1 | ||||||||||||
| -Income Tax Expense | 0.8 | 7.6 | -35.2 | -14.0 | ||||||||||||
| Income from Cont Ops | -220.4 | -1,001.2 | -200.3 | -171.1 | ||||||||||||
| -Net Extraordinary Losses | - | - | - | - | ||||||||||||
| +Discounted operations | - | - | - | - | ||||||||||||
| +XO & Accounting Changes | - | - | - | - | ||||||||||||
| Income Incl. MI | -220.4 | -1,001.2 | -200.3 | -171.1 | ||||||||||||
| -Minority Interests | - | - | - | 0.0 | ||||||||||||
| Net Income, GAAP | -220.4 | -1,001.2 | -200.3 | -171.1 | ||||||||||||
| -Prfrrd Div & Other | - | - | - | - | ||||||||||||
| Net Income Avail To Common | -220.4 | -1,001.2 | -200.3 | -171.1 | ||||||||||||
| Weighted Average Shs Out | 162,169,564.0 | 170,564,000.0 | 176,221,530.0 | 706,939,747.0 | ||||||||||||
| EPS | -1.4 | -5.9 | -1.1 | -1.0 | ||||||||||||
| Weighted Average Shs Out Dil | 164,578,219.0 | 170,564,000.0 | 176,221,530.0 | 706,939,747.0 | ||||||||||||
| EPS Diluted | -1.3 | -5.9 | -1.1 | -1.0 | ||||||||||||